https://www.nasdaq.com/press-release/abbott-hosts-conference-call-for-fourth-quarter-earnings-2022-01-04
https://www.nasdaq.com/press-release/abbotts-proclaimtm-xr-spinal-cord-stimulation-system-now-offers-expanded-mri
https://www.nasdaq.com/press-release/abbott-to-present-at-j.p.-morgan-healthcare-conference-2021-12-21
https://www.nasdaq.com/press-release/abbott-names-robert-b.-ford-chairman-of-the-board-miles-d.-white-to-retire-as
https://www.nasdaq.com/press-release/abbott-increases-quarterly-dividend-for-50th-consecutive-year-2021-12-10
https://www.nasdaq.com/press-release/abbott-launches-similacr-360-total-carer-with-exclusive-blend-of-five-hmo-prebiotics
https://www.nasdaq.com/press-release/abbott-achieves-highest-score-in-its-industry-for-the-ninth-consecutive-year-on-the
https://www.nasdaq.com/press-release/abbotts-new-leadless-pacemaker-system-meets-primary-endpoints-in-pivotal-trial-2021
https://www.nasdaq.com/press-release/abbott-and-the-american-diabetes-associationr-launch-first-of-its-kind-community
https://www.nasdaq.com/press-release/abbott-launches-new-initiative-to-drive-diversity-in-medical-research-and-improve
https://www.nasdaq.com/press-release/abbott-reports-third-quarter-2021-results-achieves-strong-double-digit-earnings
https://www.nasdaq.com/press-release/jason-sudeikis-joins-abbott-real-madrid-at-new-york-stock-exchange-to-support
https://www.nasdaq.com/press-release/abbott-and-real-madrid-team-up-to-support-the-health-and-nutrition-of-children
https://www.nasdaq.com/press-release/abbott-commits-to-reducing-malnutrition-globally-with-launch-of-abbott-center-for
https://www.nasdaq.com/press-release/abbott-hosts-conference-call-for-third-quarter-earnings-2021-09-23
https://www.nasdaq.com/press-release/abbott-receives-fda-approval-for-minimally-invasive-porticotm-with-flexnavtm-tavr
https://www.nasdaq.com/press-release/abbott-declares-391st-consecutive-quarterly-dividend-2021-09-15
https://www.nasdaq.com/press-release/abbott-expands-peripheral-vascular-offerings-with-acquisition-of-walk-vascular-llc
https://www.nasdaq.com/press-release/late-breaking-data-shows-abbotts-amplatzertm-amulettm-occluder-offers-superior-left
https://www.nasdaq.com/press-release/guide-hf-study-data-show-abbotts-cardiomemstm-device-can-improve-care-for-more
https://www.nasdaq.com/press-release/podcast%3a-how-to-find-stem-success-learn-to-pivot.-2021-08-18
https://www.nasdaq.com/press-release/strengthening-resilience-in-vulnerable-communities-2021-08-16
https://www.nasdaq.com/press-release/abbotts-amplatzertm-amulettm-device-approved-by-fda-to-treat-people-with-atrial
https://www.nasdaq.com/press-release/abbotts-freestyler-libre-2-ios-app-cleared-in-u.s.-providing-a-seamless-digital-0
https://www.nasdaq.com/press-release/a-workplace-where-collaboration-innovation-2021-08-09
https://www.nasdaq.com/press-release/a-convergence-of-challenges%3a-addressing-the-devastating-impact-of-chronic-disease-on
https://www.nasdaq.com/press-release/broader-access-is-vital-to-the-future-of-testing-and-healthcare-innovation-2021-08-04
https://www.nasdaq.com/press-release/abbott-receives-fda-clearance-for-its-imaging-technology-using-artificial
https://www.nasdaq.com/press-release/abbotts-freestyler-libre-2-ios-app-cleared-in-u.s.-providing-a-seamless-digital
https://www.nasdaq.com/press-release/new-study%3a-half-of-americans-living-with-diabetes-may-be-consuming-less-than-the
https://www.nasdaq.com/press-release/building-trust-and-improving-care-in-underserved-communities-2021-07-23
https://www.nasdaq.com/press-release/abbott-reports-second-quarter-2021-results-2021-07-22
https://www.nasdaq.com/press-release/delivering-long-term-impact%3a-abbotts-2020-sustainability-report-2021-07-15
https://www.nasdaq.com/press-release/abbotts-xience-stent-receives-fda-approval-for-shortest-blood-thinner-course-for-high
https://www.nasdaq.com/press-release/late-breaking-data-demonstrate-abbotts-freestyler-libre-system-supports-health-equity
https://www.nasdaq.com/press-release/abbott-hosts-conference-call-for-second-quarter-earnings-2021-06-25
https://www.nasdaq.com/press-release/people-who-exercise-intensely-could-improve-recovery-by-adjusting-their-hydration
https://www.nasdaq.com/press-release/abbott-earns-first-of-its-kind-recommendation-for-high-school-stem-interns-to-0
https://www.nasdaq.com/press-release/abbott-earns-first-of-its-kind-recommendation-for-high-school-stem-interns-to-receive
https://www.nasdaq.com/press-release/abbott-declares-390th-consecutive-quarterly-dividend-2021-06-11
https://www.nasdaq.com/press-release/abbott-confirms-capacity-to-support-expanded-use-of-heartmate-3tm-heart-pump-2021-06
https://www.nasdaq.com/press-release/abbott-issues-updated-2021-outlook-2021-06-01
https://www.nasdaq.com/press-release/abbott-receives-ce-mark-for-navitortm-the-latest-generation-transcatheter-aortic
https://www.nasdaq.com/press-release/abbott-seeks-better-treatment-options-for-patients-with-both-atrial-fibrillation-and
https://www.nasdaq.com/press-release/abbott-reports-first-quarter-2021-results-2021-04-20
https://www.nasdaq.com/press-release/abbott-begins-shipping-binaxnowtm-covid-19-ag-self-test-to-retailers-today-2021-04-19
https://www.nasdaq.com/press-release/worlds-fastest-marathoner-eliud-kipchoge-uses-abbotts-libre-sense-at-nn-mission
https://www.nasdaq.com/press-release/abbott-receives-ce-mark-approval-for-next-generation-tricliptm-device-offering-new
https://www.nasdaq.com/press-release/abbotts-xiencetm-stent-receives-european-approval-for-one-month-dual-anti-platelet
https://www.nasdaq.com/press-release/abbotts-binaxnowtm-rapid-antigen-self-test-receives-fda-emergency-use-authorization
https://www.nasdaq.com/press-release/abbott-hosts-conference-call-for-first-quarter-earnings-2021-03-29
https://www.nasdaq.com/press-release/abbott-announces-its-pandemic-defense-coalition%3a-a-global-network-of-expert
https://www.nasdaq.com/press-release/abbott-introduces-neurospheretm-virtual-clinic-first-of-its-kind-remote
https://www.nasdaq.com/press-release/abbott-receives-fda-eua-for-laboratory-pcr-assay-that-detects-and-differentiates-sars
https://www.nasdaq.com/press-release/abbott-researchers-find-rare-group-of-people-with-controlled-hiv-who-could-be-a-key
https://www.nasdaq.com/press-release/abbott-declares-389th-consecutive-quarterly-dividend-2021-02-19
https://www.nasdaq.com/press-release/abbott-reports-fourth-quarter-2020-results-issues-strong-double-digit-growth-forecast
https://www.nasdaq.com/press-release/abbotts-panbio-rapid-antigen-test-receives-ce-mark-for-asymptomatic-screening-and
https://www.nasdaq.com/press-release/abbott-receives-expanded-medicare-reimbursement-for-first-of-its-kind-mitracliptm
https://www.nasdaq.com/press-release/abbott-to-launch-the-neurospheretm-mypathtm-digital-health-app-designed-to-track-and
https://www.nasdaq.com/press-release/abbott-announces-fulfillment-of-federal-government-purchase-of-150-million-binaxnowtm
https://www.nasdaq.com/press-release/abbott-receives-fda-510k-clearance-for-the-first-rapid-handheld-blood-test-for
https://www.nasdaq.com/press-release/abbott-hosts-conference-call-for-fourth-quarter-earnings-2021-01-06
https://www.nasdaq.com/press-release/as-vaccines-roll-out-americans-see-covid-19-testing-as-important-partner-2020-12-22
https://www.nasdaq.com/press-release/abbott-to-present-at-j.p.-morgan-healthcare-conference-2020-12-18
https://www.nasdaq.com/press-release/fda-approves-labeling-update-for-abbotts-heartmate-3-heart-pump-for-use-in-pediatric
https://www.nasdaq.com/press-release/abbotts-binaxnow-covid-19-rapid-test-receives-fda-emergency-use-authorization-for
https://www.nasdaq.com/press-release/abbott-receives-ce-mark-for-its-covid-19-igg-quantitative-antibody-blood-test-2020-12
https://www.nasdaq.com/press-release/abbott-develops-new-pedialyter-hydration-solution-to-help-support-immune-health-2020
https://www.nasdaq.com/press-release/abbott-increases-quarterly-dividend-by-25-2020-12-11
https://www.nasdaq.com/press-release/abbotts-freestyle-libre-2-now-approved-for-adults-and-children-with-diabetes-in
https://www.nasdaq.com/press-release/abbott-becomes-first-anchor-sponsor-of-american-diabetes-associations-health-equity
https://www.nasdaq.com/press-release/abbott-named-industry-sustainability-leader-for-the-eighth-year-in-a-row-on-the-dow
https://www.nasdaq.com/press-release/abbott-announces-the-u.s.-launch-of-the-ionicrftm-generator-for-use-in-patients
https://www.nasdaq.com/press-release/abbott-wins-prestigious-prix-galien-usa-award-for-first-of-its-kind-mitracliptm
https://www.nasdaq.com/press-release/abbott-reports-third-quarter-2020-results-achieves-strong-double-digit-earnings
https://www.nasdaq.com/press-release/improved-mental-and-physical-condition-is-directly-linked-to-nutrition-study-shows
https://www.nasdaq.com/press-release/abbott-receives-fda-emergency-use-authorization-for-its-covid-19-igm-antibody-blood
https://www.nasdaq.com/press-release/abbott-releases-id-nowtm-covid-19-interim-clinical-study-results-from-1003-people-to
https://www.nasdaq.com/press-release/quanterix-enters-into-a-license-agreement-that-grants-abbott-access-to-portfolio-of
https://www.nasdaq.com/press-release/abbotts-freestyler-libre-3-system-receives-ce-mark-features-worlds-smallest-thinnest
https://www.nasdaq.com/press-release/abbott-receives-ce-mark-for-next-generation-mitracliptm-heart-valve-repair-device-to
https://www.nasdaq.com/press-release/abbott-hosts-conference-call-for-third-quarter-earnings-2020-09-21
https://www.nasdaq.com/press-release/abbott-declares-387th-consecutive-quarterly-dividend-2020-09-17
https://www.nasdaq.com/press-release/abbott-introduces-libre-sense-glucose-sport-biosensor-in-europe-worlds-first-glucose
https://www.nasdaq.com/press-release/abbott-announces-start-of-trial-to-evaluate-the-new-esprittm-btk-drug-eluting
https://www.nasdaq.com/press-release/abbotts-freestyler-libre-2-icgm-system-now-available-to-medicare-beneficiaries-2020
https://www.nasdaq.com/press-release/abbotts-fast-%245-15-minute-easy-to-use-covid-19-antigen-test-receives-fda-emergency
https://www.nasdaq.com/press-release/abbott-announces-start-of-study-to-evaluate-new-device-to-treat-recurrent-atrial
https://www.nasdaq.com/press-release/abbott-receives-fda-approval-for-ios-compatible-app-allowing-people-living-with
https://www.nasdaq.com/press-release/abbott-reports-second-quarter-2020-results-exceeds-analysts-expectations-2020-07-16
https://www.nasdaq.com/press-release/abbott-agrees-to-global-transcatheter-litigation-settlement-with-edwards-lifesciences
https://www.nasdaq.com/press-release/abbott-receives-fda-approval-for-new-heart-rhythm-devices-featuring-bluetooth
https://www.nasdaq.com/press-release/abbott-to-initiate-trial-to-study-mitraclip-as-an-option-for-moderate-surgical-risk
https://www.nasdaq.com/press-release/fda-approves-less-invasive-surgical-approach-for-abbotts-heart-pump-to-help-patients
https://www.nasdaq.com/press-release/abbott-raises-quarterly-dividend-12.5-increasing-payouts-for-48-straight-years-2019
https://www.nasdaq.com/press-release/abbott-announces-robert-b.-ford-to-succeed-miles-d.-white-as-chief-executive-officer
https://www.nasdaq.com/press-release/abbott-announces-discovery-of-new-strain-of-hiv-keeping-global-health-community-a
https://www.nasdaq.com/press-release/the-australian-red-cross-blood-service-selects-abbotts-alinity-s-solution-for-blood
https://www.nasdaq.com/press-release/latin-american-countries-offer-unique-benefits-cannabis-cultivators-2019-04-21
